Toll Free: 1-888-928-9744

Toyama Chemical Co., Ltd. - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 47 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Toyama Chemical Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Toyama Chemical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Toyama Chemical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Toyama Chemical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Toyama Chemical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Toyama Chemical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Toyama Chemical Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate Toyama Chemical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Toyama Chemical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Toyama Chemical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Toyama Chemical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Toyama Chemical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Toyama Chemical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Toyama Chemical Co., Ltd. Snapshot 5
Toyama Chemical Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Toyama Chemical Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Toyama Chemical Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Toyama Chemical Co., Ltd. - Pipeline Products Glance 12
Toyama Chemical Co., Ltd. - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
Phase III Products/Combination Treatment Modalities 13
Toyama Chemical Co., Ltd. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Toyama Chemical Co., Ltd. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Toyama Chemical Co., Ltd. - Drug Profiles 17
garenoxacin mesylate 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
favipiravir 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ozenoxacin 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
T-5224 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
T-817MA 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
solithromycin 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
T-2307 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
T-1106 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Toyama Chemical Co., Ltd. - Pipeline Analysis 30
Toyama Chemical Co., Ltd. - Pipeline Products by Target 30
Toyama Chemical Co., Ltd. - Pipeline Products by Route of Administration 31
Toyama Chemical Co., Ltd. - Pipeline Products by Molecule Type 32
Toyama Chemical Co., Ltd. - Pipeline Products by Mechanism of Action 33
Toyama Chemical Co., Ltd. - Recent Pipeline Updates 34
Toyama Chemical Co., Ltd. - Dormant Projects 44
Toyama Chemical Co., Ltd. - Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Appendix 46
Methodology 46
Coverage 46
Secondary Research 46
Primary Research 46
Expert Panel Validation 46
Contact Us 47
Disclaimer 47
List of Tables
Toyama Chemical Co., Ltd., Key Information 5
Toyama Chemical Co., Ltd., Key Facts 5
Toyama Chemical Co., Ltd. - Pipeline by Indication, 2014 7
Toyama Chemical Co., Ltd. - Pipeline by Stage of Development, 2014 8
Toyama Chemical Co., Ltd. - Monotherapy Products in Pipeline, 2014 9
Toyama Chemical Co., Ltd. - Partnered Products in Pipeline, 2014 10
Toyama Chemical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
Toyama Chemical Co., Ltd. - Pre-Registration, 2014 12
Toyama Chemical Co., Ltd. - Phase III, 2014 13
Toyama Chemical Co., Ltd. - Phase II, 2014 14
Toyama Chemical Co., Ltd. - Phase I, 2014 15
Toyama Chemical Co., Ltd. - Preclinical, 2014 16
Toyama Chemical Co., Ltd. - Pipeline by Target, 2014 30
Toyama Chemical Co., Ltd. - Pipeline by Route of Administration, 2014 31
Toyama Chemical Co., Ltd. - Pipeline by Molecule Type, 2014 32
Toyama Chemical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 33
Toyama Chemical Co., Ltd. - Recent Pipeline Updates, 2014 34
Toyama Chemical Co., Ltd. - Dormant Developmental Projects,2014 44
Toyama Chemical Co., Ltd., Other Locations 45
Toyama Chemical Co., Ltd., Subsidiaries 45 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify